Because standard of care with pegylated interferon plus ribavirin therapy is costly, has significant side effects, and fails to cure about half of all infections, many patients seek complementary and alternative medicine
to improve their health, such as Silymarin, derived
from milk thistle (Silybum marianum).
Milk thistle's clinical benefits for chronic hepatitis C are unsettled due to variability in standardization of the herbal product.